Physician profile
Larisa Vorobyeva
NPI 1194971069
$1,187.92
in general payments reported to CMS, 2019-2025
16 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.82 · 2020: $159 · 2021: $202 · 2022: $215 · 2023: $191 · 2024: $125 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $202.35 | 2019-2022 | |
| Abbvie INC. | $181.17 | 2021-2024 | Liletta |
| Exeltis, USA INC. | $164.88 | 2019-2023 | Slynd |
| Shield Therapeutics INC | $154.94 | 2023-2025 | Accrufer |
| Hologic Sales and Service, LLC | $145.27 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $73.00 | 2023-2024 | |
| Coopersurgical, INC. | $46.87 | 2022-2023 | Paragard T 380a |
| Myovant Sciences INC. | $37.94 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.33 | 2022 | |
| Sumitomo Pharma America, INC. | $24.89 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $24.29 | 2019 | |
| Millicent US INC | $23.58 | 2024 | Femring, Intrarosa |
| Lupin INC. | $21.44 | 2020 | |
| Becton, Dickinson and Company | $20.76 | 2022 | |
| Astellas Pharma US INC | $20.17 | 2025 | Veozah |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larisa Vorobyeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.